Table 2.
Physical activity, fitness measures, and TAC in men with CHD and in their peers without CHD.
| Variable | Group I (CHD patients) n = 90 |
Group II (without CHD) n = 90 |
|---|---|---|
| Energy expenditure for LTPA (kcal·week−1) | 1187 ± 1668 † | 2320 ± 2707 |
| Energy expenditure for LTPA (kcal·week−1·kg−1) | 14.1 ± 19.5 † | 30.2 ± 36.0 |
| PWC85%HRmax (W) | 133.5 ± 41.1 ‡ | 157.0 ± 36.6 |
| PWC85%HRmax/kg (W·kg−1) | 1.56 ± 0.47 ‡ | 1.95 ± 0.53 |
| TAC-FRAS (mmol FeCl2·L−1) | 1.37 ± 0.28 * | 1.27 ± 0.23 |
| TAC-DPPH (% reduction) | 10.2 ± 3.5 | 11.3 ± 4.6 |
* P < 0.05, † P < 0.01, and ‡ P < 0.001 as compared to the healthy subjects.
LTPA: leisure time physical activity, PWC: physical working capacity, HR: heart rate, TAC: total antioxidant capacity, FRAS: Ferric Reducing Ability of Serum, DPPH: 2.2-diphenyl-1-picryl-hydrazyl, and CHD: coronary heart disease.